Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial
VXM01（一种针对 VEGF 受体 2 的口服 T 细胞疫苗）对晚期胰腺癌患者的抗血管生成活性：一项随机、安慰剂对照的 1 期试验
期刊:Oncoimmunology
影响因子:
doi:10.1080/2162402X.2014.1001217
Friedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, Tobias Friedrich, Heinz Lubenau, Marco Springer, Klaus M Breiner, Gerd Mikus, Jürgen Weitz, Alexis Ulrich, Markus W Buechler, Frank Pianka, Ulla Klaiber, Markus Diener, Christine Leowardi, Simon Schimmack, Leila Sisic, Anne-Valer
免疫
细胞生物学
胰腺癌
肿瘤细胞
Angiogenesis
